BACKGROUND: Because they generally are older and frequently have co-morbidities, patients with type 2 diabetes mellitus and end-stage renal disease seldom are selected for renal transplantation. Thus, information on transplantation results from controlled studies in this high-risk category of patients is scarce. We have compared the results of kidney transplantations in type 2 diabetic patients with carefully matched non-diabetic subjects. METHODS: All first cadaveric renal transplants performed in type 2 diabetic patients from January 1, 1988 to December 31, 1998 in our centre were included. Non-diabetic controls were individually matched with diabetic patients with respect to year of transplantation, sex, age, selected immunological parameters, and graft cold ischaemia. RESULTS: We included 64 type 2 diabetic and 64 non-diabetic patients who were followed for a mean period of 37+/-27 and 41+/-31 months, respectively, after renal transplantation. Patient survival at 1 and 5 years post-transplant was 85 and 69 vs 84 and 74% (P=0.43, NS), while graft survival rates censored for patient death were 84 and 77 vs 82 and 77% for diabetic and non-diabetic subjects, respectively (P=0.52, NS). With graft survival results not censored for death with functioning graft, no significant change was seen (diabetic vs non-diabetic group: 77 and 54 vs 73 and 61%, P=0.19, NS). Age, but not the presence of diabetes, was the only factor significantly affecting patient survival when both patient groups were pooled. With regard to post-transplant complications requiring hospitalization, there was a significant difference only in the number of patients who had amputations (diabetic vs non-diabetic group: 8 vs 0, P=0.01). CONCLUSIONS: Patient and graft survival after kidney transplantation was similar in type 2 diabetic and matched non-diabetic subjects, with more amputations occurring in the diabetic group. Thus, at a single-centre level renal transplantation results almost equivalent to those in non-diabetic patients may be achieved in type 2 diabetes mellitus.
BACKGROUND: Because they generally are older and frequently have co-morbidities, patients with type 2 diabetes mellitus and end-stage renal disease seldom are selected for renal transplantation. Thus, information on transplantation results from controlled studies in this high-risk category of patients is scarce. We have compared the results of kidney transplantations in type 2 diabeticpatients with carefully matched non-diabetic subjects. METHODS: All first cadaveric renal transplants performed in type 2 diabeticpatients from January 1, 1988 to December 31, 1998 in our centre were included. Non-diabetic controls were individually matched with diabeticpatients with respect to year of transplantation, sex, age, selected immunological parameters, and graft cold ischaemia. RESULTS: We included 64 type 2 diabetic and 64 non-diabeticpatients who were followed for a mean period of 37+/-27 and 41+/-31 months, respectively, after renal transplantation. Patient survival at 1 and 5 years post-transplant was 85 and 69 vs 84 and 74% (P=0.43, NS), while graft survival rates censored for patientdeath were 84 and 77 vs 82 and 77% for diabetic and non-diabetic subjects, respectively (P=0.52, NS). With graft survival results not censored for death with functioning graft, no significant change was seen (diabetic vs non-diabetic group: 77 and 54 vs 73 and 61%, P=0.19, NS). Age, but not the presence of diabetes, was the only factor significantly affecting patient survival when both patient groups were pooled. With regard to post-transplant complications requiring hospitalization, there was a significant difference only in the number of patients who had amputations (diabetic vs non-diabetic group: 8 vs 0, P=0.01). CONCLUSIONS:Patient and graft survival after kidney transplantation was similar in type 2 diabetic and matched non-diabetic subjects, with more amputations occurring in the diabetic group. Thus, at a single-centre level renal transplantation results almost equivalent to those in non-diabeticpatients may be achieved in type 2 diabetes mellitus.
Authors: Vivek B Kute; Aruna V Vanikar; Hargovind L Trivedi; Pankaj R Shah; Kamal R Goplani; Manoj R Gumber; Himanshu V Patel; Suraj M Godara; Pranjal R Modi; Veena R Shah Journal: Int Urol Nephrol Date: 2010-11-24 Impact factor: 2.370
Authors: Chung Hee Baek; Hyosang Kim; Seung Don Baek; Mun Jang; Wonhak Kim; Won Seok Yang; Duck Jong Han; Su-Kil Park Journal: Korean J Intern Med Date: 2017-08-21 Impact factor: 2.884
Authors: Claudia Sommerer; Oliver Witzke; Frank Lehner; Wolfgang Arns; Petra Reinke; Ute Eisenberger; Bruno Vogt; Katharina Heller; Johannes Jacobi; Markus Guba; Rolf Stahl; Ingeborg A Hauser; Volker Kliem; Rudolf P Wüthrich; Anja Mühlfeld; Barbara Suwelack; Michael Duerr; Eva-Maria Paulus; Martin Zeier; Martina Porstner; Klemens Budde Journal: BMC Nephrol Date: 2018-09-19 Impact factor: 2.388
Authors: Erika B Rangel; João R de Sá; Cláudio S Melaragno; Adriano M Gonzalez; Marcelo M Linhares; Alcides Salzedas; José O Medina-Pestana Journal: Diabetol Metab Syndr Date: 2009-08-26 Impact factor: 3.320
Authors: Ja Young Jeon; Soo Jung Kim; Kyoung Hwa Ha; Ji Hyun Park; Bumhee Park; Chang-Kwon Oh; Seung Jin Han Journal: J Diabetes Investig Date: 2020-09-30 Impact factor: 4.232